← Back to Search

Noom Health for Weight Loss

N/A
Waitlist Available
Led By Thomas Hildebrandt, PsyD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages of 18 and 60 at entry to the study
Participants must be interested in the Noom app
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 30 months
Awards & highlights

Study Summary

This trial will compare the Noom mobile app with a control for weight loss, quality of life, and self-reported health status. Noom Health is expected to be more successful than the control, especially for participants who are older, have less support, have more health conditions, and have more psychosocial problems.

Who is the study for?
This trial is for adults aged 18-60 with a BMI over 27 who want to manage their weight using the Noom app. They must speak English and not be current Noom users, pregnant, at risk of suicide, or have health issues related to smartphone use.Check my eligibility
What is being tested?
The study compares two versions of the Noom program: 'Noom Health' and 'Noom Digital Health'. It will assess which is better for weight loss, quality of life, psychosocial functioning, and self-reported health status after intervention and in maintaining long-term weight loss.See study design
What are the potential side effects?
Since this trial involves digital health programs rather than medications or medical procedures, traditional side effects are not expected. However, participants may experience psychological impacts or stress related to lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old.
Select...
I am interested in using the Noom app.
Select...
I am between 18 and 60 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Weight from Baseline to 30 Months
Change in Weight from Baseline to 6 Months
Secondary outcome measures
12-Month Completion Status
Adherence to intervention measured using a percentage of the total number of available app features used from Baseline to 6 Months
Anxiety
+12 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Noom HealthExperimental Treatment1 Intervention
Group II: Noom Digital HealthActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
852 Previous Clinical Trials
535,332 Total Patients Enrolled
1 Trials studying Weight Loss
53 Patients Enrolled for Weight Loss
Noom Inc.Industry Sponsor
15 Previous Clinical Trials
1,861 Total Patients Enrolled
5 Trials studying Weight Loss
545 Patients Enrolled for Weight Loss
Thomas Hildebrandt, PsyDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
1 Previous Clinical Trials
120 Total Patients Enrolled

Media Library

Noom Digital Health Clinical Trial Eligibility Overview. Trial Name: NCT04797169 — N/A
Weight Loss Research Study Groups: Noom Health, Noom Digital Health
Weight Loss Clinical Trial 2023: Noom Digital Health Highlights & Side Effects. Trial Name: NCT04797169 — N/A
Noom Digital Health 2023 Treatment Timeline for Medical Study. Trial Name: NCT04797169 — N/A
Weight Loss Patient Testimony for trial: Trial Name: NCT04797169 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For whom is this clinical research program accessible?

"This trial seeks 600 obese individuals aged between 18 and 60. To be eligible, applicants must possess a BMI exceeding 27 kg/m2, commit to using the Noom app, and naturally fit within the specified age range."

Answered by AI

Is the participant eligibility for this investigation limited to adults over a certain age?

"Patients aged 18 to 60 are eligible for this trial. For minors and seniors, there are 236 trials tailored specifically to those under the age of 18, and 715 that cater to individuals over 65 years old."

Answered by AI

Are recruitment efforts for this experiment still underway?

"According to information hosted on clinicaltrials.gov, participation in this medical trial has ceased as of September 21st 2022. The trial initially began recruiting participants on March 22nd 2021 but is not currently seeking any more patients; however, there are 1,134 other studies that are actively open for enrollment at the moment."

Answered by AI

What objectives is this clinical trial hoping to accomplish?

"According to the trial's sponsor, Noom Inc., primary outcomes measured over a Baseline and 24 Month period include Change in Weight from Baseline to 6 Months. Additionally, secondary metrics like Adherence to intervention (percent of available app features used relative to baseline at 12 months), Change in Mental Composite Score via SF-36 from Baseline to 24 Months, and Alteration in Anxiety on DASS scale between Baseline and 24 Months will be evaluated as well."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
New Jersey
Alabama
Other
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
Department of Psychiatry, Eating and Weight Disorders Program
How many prior treatments have patients received?
3+
2

Why did patients apply to this trial?

Need to lose 40 lbs. I need motivation to lose weight. I am hoping this trial can help address my medical concern.
PatientReceived 2+ prior treatments
I am interested in using Noom. I tried once before but didn't have enough motivation.
PatientReceived 2+ prior treatments
~46 spots leftby Jul 2024